Published in Neuromuscul Disord on December 10, 2011
MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms. J Clin Invest (2014) 0.92
Behavioral and locomotor measurements using an open field activity monitoring system for skeletal muscle diseases. J Vis Exp (2014) 0.86
Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. Hum Mol Genet (2015) 0.84
Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy. PLoS One (2015) 0.81
Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling. Hum Mol Genet (2013) 0.80
Cardiac function in muscular dystrophy associates with abdominal muscle pathology. J Neuromuscul Dis (2015) 0.78
The FVB Background Does Not Dramatically Alter the Dystrophic Phenotype of Mdx Mice. PLoS Curr (2015) 0.77
The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse. Toxicol Rep (2015) 0.77
Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients. J Neuromuscul Dis (2015) 0.77
A reporter mouse for optical imaging of inflammation in mdx muscles. Skelet Muscle (2015) 0.76
Novel, high incidence exercise-induced muscle bleeding model in hemophilia B mice: rationale, development and prophylactic intervention. J Thromb Haemost (2014) 0.75
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 5.58
Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol (1988) 4.97
Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev (2002) 4.80
Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell (1997) 3.68
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol (1997) 3.32
Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med (2009) 3.27
Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest (2007) 2.99
Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature (2008) 2.87
The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. Muscle Nerve (2010) 2.78
Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet (2008) 2.27
Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve (2009) 2.19
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther (2011) 2.06
Mice without myoglobin. Nature (1998) 1.78
Functional deficits in nNOSmu-deficient skeletal muscle: myopathy in nNOS knockout mice. PLoS One (2008) 1.42
Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol (1997) 1.37
mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet (1998) 1.32
Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J Neurochem (1998) 1.24
Research ethics. Beyond access vs. protection in trials of innovative therapies. Science (2010) 1.23
Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. Mamm Genome (2000) 1.23
Use of step activity monitoring for continuous physical activity assessment in boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil (2005) 1.21
Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am J Phys Med Rehabil (1998) 1.19
Voluntary exercise decreases progression of muscular dystrophy in diaphragm of mdx mice. J Appl Physiol (1985) (1994) 1.13
An assessment of handedness in mice. Physiol Behav (1991) 1.11
Comparative MRI analysis of T2 changes associated with single and repeated bouts of downhill running leading to eccentric-induced muscle damage. J Appl Physiol (1985) (2008) 1.11
Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance. Eur Heart J (2008) 1.11
Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord (1995) 1.09
Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice. Muscle Nerve (2010) 0.94
Gait patterns comparison of children with Duchenne muscular dystrophy to those of control subjects considering the effect of gait velocity. Gait Posture (2010) 0.91
On the inheritance of handedness. I. Laterality in inbred mice. J Hered (1968) 0.90
The effects of rod and cone loss on the photic regulation of locomotor activity and heart rate. Eur J Neurosci (2008) 0.87
Muscle injury after repeated bouts of voluntary and electrically stimulated exercise. Med Sci Sports Exerc (2008) 0.84
Handedness in mice: comparison across eleven inbred strains. Behav Genet (1991) 0.81
Creatine kinase release and clearance using MM variants following repeated bouts of eccentric exercise. Med Sci Sports Exerc (1998) 0.80
Adenosine A(3) receptor stimulation induces protection of skeletal muscle from eccentric exercise-mediated injury. Am J Physiol Regul Integr Comp Physiol (2010) 0.78
Defective membrane repair in dysferlin-deficient muscular dystrophy. Nature (2003) 6.50
Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature (2010) 6.25
Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med (2004) 5.59
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature (2002) 5.21
Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med (2002) 5.07
Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature (2002) 3.96
Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci (2006) 3.92
Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science (2003) 3.21
Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev (2002) 3.15
Auxiliary subunits: essential components of the voltage-gated calcium channel complex. Curr Opin Neurobiol (2003) 3.10
Structural analysis of the voltage-dependent calcium channel beta subunit functional core and its complex with the alpha 1 interaction domain. Neuron (2004) 3.05
LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat Med (2004) 3.00
O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Science (2010) 2.98
Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature (2008) 2.87
PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev (2007) 2.79
Dystrophin-glycoprotein complex: post-translational processing and dystroglycan function. J Biol Chem (2003) 2.56
Dysferlin and the plasma membrane repair in muscular dystrophy. Trends Cell Biol (2004) 2.41
Are voltage-dependent ion channels involved in the endothelial cell control of vasomotor tone? Am J Physiol Heart Circ Physiol (2007) 2.41
New World arenavirus clade C, but not clade A and B viruses, utilizes alpha-dystroglycan as its major receptor. J Virol (2002) 2.35
Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell (2004) 2.33
Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science (2012) 2.22
Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding. J Virol (2005) 2.17
Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. Science (2003) 2.05
The unfolded protein response mediates adaptation to exercise in skeletal muscle through a PGC-1α/ATF6α complex. Cell Metab (2011) 2.02
Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell (2002) 2.01
RIM1 confers sustained activity and neurotransmitter vesicle anchoring to presynaptic Ca2+ channels. Nat Neurosci (2007) 1.95
ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nat Genet (2012) 1.93
Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest (2007) 1.88
Dysferlin and muscle membrane repair. Curr Opin Cell Biol (2007) 1.82
Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron (2003) 1.80
Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle. J Gen Physiol (2010) 1.73
A dystroglycan mutation associated with limb-girdle muscular dystrophy. N Engl J Med (2011) 1.67
Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol (2006) 1.59
SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function. Science (2013) 1.57
Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy. J Neurosci (2008) 1.54
Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. Am J Hum Genet (2013) 1.50
Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring. J Cell Sci (2006) 1.49
Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc Natl Acad Sci U S A (2002) 1.47
C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol (2007) 1.47
Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence. Proc Natl Acad Sci U S A (2011) 1.47
Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proc Natl Acad Sci U S A (2009) 1.47
Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. Am J Hum Genet (2013) 1.47
Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. J Biol Chem (2009) 1.46
Exercise-induced left ventricular systolic dysfunction in women heterozygous for dystrophinopathy. J Am Soc Echocardiogr (2010) 1.43
The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res (2009) 1.34
Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol (2006) 1.34
The voltage-dependent calcium channel beta subunit contains two stable interacting domains. J Biol Chem (2003) 1.33
Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation. J Neurosci (2002) 1.33
Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res (2004) 1.33
Glycomic analyses of mouse models of congenital muscular dystrophy. J Biol Chem (2011) 1.32
Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Proc Natl Acad Sci U S A (2011) 1.32
Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. J Neurosci (2005) 1.30
Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response. Virology (2010) 1.28
A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity. Brain Pathol (2008) 1.27
Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J (2002) 1.26
Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci (2007) 1.25
Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands. J Virol (2007) 1.24
Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest (2010) 1.23
Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. J Neurosci (2008) 1.22
Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. J Neurosci (2010) 1.20
CaV3.2 is the major molecular substrate for redox regulation of T-type Ca2+ channels in the rat and mouse thalamus. J Physiol (2006) 1.18
Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J Neurosci (2008) 1.14
Long-term skeletal muscle protection after gene transfer in a mouse model of LGMD-2D. Mol Ther (2007) 1.13
Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2. Genes Dev (2005) 1.13
Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. FEBS Lett (2005) 1.12
Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell. Mol Biol Cell (2007) 1.12
Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan. Neuromuscul Disord (2005) 1.12
An HMGA2-IGF2BP2 axis regulates myoblast proliferation and myogenesis. Dev Cell (2012) 1.10
Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Hum Mol Genet (2008) 1.10
Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Hum Mol Genet (2002) 1.10
Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy. J Clin Invest (2012) 1.08
The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi. Infect Immun (2010) 1.06
Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice. Skelet Muscle (2011) 1.06
Opposing roles of integrin alpha6Abeta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation. Mol Biol Cell (2003) 1.05
Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. Hum Mol Genet (2011) 1.05
LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature (2013) 1.04
Sarcoglycan complex: implications for metabolic defects in muscular dystrophies. J Biol Chem (2009) 1.04
Modified cardiovascular L-type channels in mice lacking the voltage-dependent Ca2+ channel beta3 subunit. J Biol Chem (2003) 1.03
ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain (2013) 1.03
Dystroglycan matrix receptor function in cardiac myocytes is important for limiting activity-induced myocardial damage. Circ Res (2009) 1.03
Interactions of intermediate filament protein synemin with dystrophin and utrophin. Biochem Biophys Res Commun (2006) 1.03
Evidence for a role of dystroglycan regulating the membrane architecture of astroglial endfeet. Eur J Neurosci (2011) 1.02
Fukutin-related protein associates with the sarcolemmal dystrophin-glycoprotein complex. J Biol Chem (2007) 1.01
Gamma subunit of voltage-activated calcium channels. J Biol Chem (2003) 1.00
Muscles of mice deficient in alpha-sarcoglycan maintain large masses and near control force values throughout the life span. Physiol Genomics (2005) 1.00
Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination. Proc Natl Acad Sci U S A (2003) 0.99
Proteomic analysis of plasma membrane and secretory vesicles from human neutrophils. Proteome Sci (2007) 0.97
Insulin resistance in striated muscle-specific integrin receptor beta1-deficient mice. J Biol Chem (2008) 0.97
Long-term regulation of voltage-gated Ca(2+) channels by gabapentin. FEBS Lett (2002) 0.96
Rab3-interacting molecule gamma isoforms lacking the Rab3-binding domain induce long lasting currents but block neurotransmitter vesicle anchoring in voltage-dependent P/Q-type Ca2+ channels. J Biol Chem (2010) 0.96
Expression, localization and functions in acrosome reaction and sperm motility of Ca(V)3.1 and Ca(V)3.2 channels in sperm cells: an evaluation from Ca(V)3.1 and Ca(V)3.2 deficient mice. J Cell Physiol (2007) 0.95
Visual impairment in the absence of dystroglycan. J Neurosci (2009) 0.94
Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable. Hum Mol Genet (2002) 0.94